n-(2-(diethylamino)ethyl)-4-iodobenzamide has been researched along with Metastase in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bacin, FJ; Bonafous, JF; Bussiere, F; Chossat, FM; Madelmont, JC; Mauclaire, LP; Michelot, JM; Moreau, MF; Souteyrand, PA; Veyre, AJ | 1 |
1 trial(s) available for n-(2-(diethylamino)ethyl)-4-iodobenzamide and Metastase
Article | Year |
---|---|
Phase II scintigraphic clinical trial of malignant melanoma and metastases with iodine-123-N-(2-diethylaminoethyl 4-iodobenzamide).
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Benzamides; Female; Humans; Iodine Radioisotopes; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Radionuclide Imaging; Sensitivity and Specificity | 1993 |